登录
视频精讲 口语朗读
语篇类型：新闻报道
难度星级：★★★★★
建议用时：/7 min
参考答案：P47
中国获批全球首个可植入式脑机接口医疗设备
On March 13, 2026, China's National Medical Products Administration approved the world's first commercial implantable BCI(商用可植入脑机接口) device for medical use. The NEO System was developed by Shanghai's Neuracle and Tsinghua University. It has made China a leader in global brain technology.
The device is made for patients aged 18 to 60 with cervical spinal cord injuries(颈脊髓损伤), who can't move their hands freely. It uses a simple, safe implant and does not touch brain tissue(脑组织) directly, so it has low medical risks. The system reads brain signals and controls a robotic glove, helping patients pick up things, drink and finish daily tasks on their own.
Thirty-two patients took part in tests in 11 major Chinese hospitals. All of them had better hand control, and nearly 69 percent still had improved nerve function even after stopping using the device. While top foreign companies are still doing clinical tests, China has become the first country to put this technology into real patient use.
This new technology brings hope to millions of paralyzed people and shows China's progress in top medical research. It also shows the growing strength of Chinese innovation and the country's ability to improve real lives around the world. However, experts say BCI technology is still new, and its long-term effects need more study.
(
A. Tsinghua University and a Shanghai company.
B. China's National Medical Products Administration.
C. 11 major Chinese hospitals.
D. Thirty-two injured patients.
(
A. Control their brain signals directly.
B. Finish daily tasks by themselves.
C. Touch brain tissue safely.
D. Walk and run as fast as healthy people.
(
A. The device has high medical risks for patients.
B. Foreign companies have already used this technology.
C. The device is suitable for patients aged from 18 to 60.
D. People have studied deeply for hundreds of years.
词汇积累
approve /əˈpruːv/ v. 批准
device /dɪˈvaɪs/ n. 设备；装置
语法充电
1. long-term effects：长期影响。
语篇类型：新闻报道
难度星级：★★★★★
建议用时：/7 min
参考答案：P47
中国获批全球首个可植入式脑机接口医疗设备
On March 13, 2026, China's National Medical Products Administration approved the world's first commercial implantable BCI(商用可植入脑机接口) device for medical use. The NEO System was developed by Shanghai's Neuracle and Tsinghua University. It has made China a leader in global brain technology.
The device is made for patients aged 18 to 60 with cervical spinal cord injuries(颈脊髓损伤), who can't move their hands freely. It uses a simple, safe implant and does not touch brain tissue(脑组织) directly, so it has low medical risks. The system reads brain signals and controls a robotic glove, helping patients pick up things, drink and finish daily tasks on their own.
Thirty-two patients took part in tests in 11 major Chinese hospitals. All of them had better hand control, and nearly 69 percent still had improved nerve function even after stopping using the device. While top foreign companies are still doing clinical tests, China has become the first country to put this technology into real patient use.
This new technology brings hope to millions of paralyzed people and shows China's progress in top medical research. It also shows the growing strength of Chinese innovation and the country's ability to improve real lives around the world. However, experts say BCI technology is still new, and its long-term effects need more study.
(
A
)1. 细节理解 Who developed the NEO System together?A. Tsinghua University and a Shanghai company.
B. China's National Medical Products Administration.
C. 11 major Chinese hospitals.
D. Thirty-two injured patients.
(
B
)2. What can the BCI device help patients do?A. Control their brain signals directly.
B. Finish daily tasks by themselves.
C. Touch brain tissue safely.
D. Walk and run as fast as healthy people.
(
C
)3. Which of the following is TRUE according to the passage?A. The device has high medical risks for patients.
B. Foreign companies have already used this technology.
C. The device is suitable for patients aged from 18 to 60.
D. People have studied deeply for hundreds of years.
词汇积累
approve /əˈpruːv/ v. 批准
device /dɪˈvaɪs/ n. 设备；装置
语法充电
1. long-term effects：长期影响。
答案
1. A 细节理解题。文章明确指出，NEO 系统由上海博睿康医疗科技(Neuracle)与清华大学联合研发。(“The NEO System was developed by Shanghai's Neuracle and Tsinghua University.”)A 选项“清华大学与一家上海企业”与原文信息完全匹配。B 错误:国家药品监督管理局是该设备的审批机构。C 错误:11 家国内大型医院是开展临床试验的单位，并非研发主体。D 错误:32 名伤病患者是本次试验的受试对象。
2. B 细节理解题。文中第二段明确提到“The system reads brain signals and controls a robotic glove, helping patients pick up things, drink and finish daily tasks on their own.”(该设备可以读取大脑信号、操控机械手套，帮助患者独立完成各类日常事务)与 B 选项表述完全对应。A 错误，设备是读取大脑信号，并非让患者直接控制自身大脑信号;C 错误，原文明确说明设备不会直接接触脑组织;D 错误，文章全程未提及。
3. C 细节理解题。第二段开头提到“The device is made for patients aged 18 to 60 with cervical spinal cord injuries”(该设备专为 18 至 60 岁患有颈脊髓损伤的患者设计)，与 C 选项相符。A 错误。原文明确标注该设备 has low medical risks(医疗风险低);B 错误。原文指出海外顶尖企业仍处于临床试验阶段，尚未投入实际临床使用;D 错误。文末专家表明脑机接口技术依旧是新兴技术，长期影响仍需研究，并非已有数百年的研究积淀。
2. B 细节理解题。文中第二段明确提到“The system reads brain signals and controls a robotic glove, helping patients pick up things, drink and finish daily tasks on their own.”(该设备可以读取大脑信号、操控机械手套，帮助患者独立完成各类日常事务)与 B 选项表述完全对应。A 错误，设备是读取大脑信号，并非让患者直接控制自身大脑信号;C 错误，原文明确说明设备不会直接接触脑组织;D 错误，文章全程未提及。
3. C 细节理解题。第二段开头提到“The device is made for patients aged 18 to 60 with cervical spinal cord injuries”(该设备专为 18 至 60 岁患有颈脊髓损伤的患者设计)，与 C 选项相符。A 错误。原文明确标注该设备 has low medical risks(医疗风险低);B 错误。原文指出海外顶尖企业仍处于临床试验阶段，尚未投入实际临床使用;D 错误。文末专家表明脑机接口技术依旧是新兴技术，长期影响仍需研究，并非已有数百年的研究积淀。
